Sustainability
Corporate Governance
Risk Management and Information Disclosure
At Hisamitsu Pharmaceutical, we identify and strive to reduce a wide variety of internal and external risks in order to continue and develop our business operations. We have established an appropriate risk management structure based on scenarios for responding to various risks, such as natural disasters and other contingencies, as well as threats against the security of information, including personal information, and the protection of intellectual property.
Business Risk Management
Hisamitsu Pharmaceutical addresses various business risks in a proper and effective manner, and formulates Business Risk Management Policy to minimize the impact if any business risk arises. We have established a company-wide risk management structure requiring each department head to report on the department’s response to business risks, strategic planning, decision making, etc. at the Management Advisory Board every quarter. Meanwhile, we have designated the COVID-19 pandemic as an “emergency risk that might threaten our continuation” and launched a COVID-19 task force early in the crisis.
Although infection control measures are executed throughout the company, we are also proceeding with work reform and other measures.
Information Security
We have formulated the Information Security Management Regulations to properly manage our information assets, such as personal information and trade secrets, and established an appropriate information system management structure, thereby striving to prevent information leakage and reinforcing information security.
In addition, we take measures to keep pace with changes in the social environment and technological advances, such as countermeasures against cyberattacks, which have become a threat in recent years. In addition, information security awareness is raised by continuously alerting and educating relevant employees.
Business Continuity Plan (BCP)
Leveraging our experience of the Great East Japan Earthquake, Hisamitsu Pharmaceutical will restore business operations promptly in the event of a disaster and sustain the medical care structure by maintaining quality of pharmaceutical products and ensuring their stable supply. To secure a stable supply of pharmaceutical products, we have decentralized our production and logistics bases and concluded purchase contracts with different suppliers. We have also installed in-house power generators, established an emergency contact system, and taken various measures to minimize disaster risks in accordance with the Disaster Preparedness Manual.
●Examples of Disaster and Information Security Measures
Disaster simulation drill | Each business site has established own response team, and conducts drills in preparation for disasters by establishing an action plan in cooperation with the Disaster Response Task Force, which oversees these teams. |
---|---|
Regular drills for an emergency contact system for safety confirmation | In order to promptly confirm the safety of employees and provide accurate information to their families in the event of a disaster, regular drills are conducted for all employees to report the situation simultaneously using a cell phone e-mail service. |
Wireless and satellite phone communication testing | Wireless and satellite telephones are installed at our main bases in Japan (Kyushu Head Office, Tokyo Head Office, Utsunomiya Factory, and Tsukuba Laboratory), and drills are conducted to prepare for disasters. |
Voluntary fire brigade | Each business site has organized a voluntary fire brigade and regularly conducts evacuation and fire drills. For plants in Japan, the fire brigades regularly engage in fire drills and a water-discharge drills using outdoor hydrants in line with our fire defense plan and receive instructions and feedbacks from their local fire station. |
Emergency kits and food stockpiles | We have distributed emergency kits to all employees to prepare for an emergency. Each business site keeps a stockpile of water and food in case employees are stranded due to disruption of the transportation system in the event of an emergency. |
Securing logistics routes | Land transportation using trucks is shifted to sea transportation, thereby aiming to ensure a logistics channel in the event of an emergency. |
Information security | As cyber-attacks are spreading around the world, exercise drills are conducted for all employees on how to respond when they receive suspicious e-mails (including distribution of pseudo-targeted attack e-mails that are actually disguised as normal e-mails). |
Information Disclosure
Hisamitsu Pharmaceutical has established the Disclosure Policy Regulations to ensure timely and appropriate disclosure of corporate information. In addition to corporate information required to be disclosed in a timely manner by the Financial Instruments and Exchange Act and the Timely Disclosure Rules stipulated by the Tokyo Stock Exchange, the Company deems information that does not fall under the scope of the Timely Disclosure Rules, but may have an impact on investment decisions as Material Disclosure Information, and strives to disclose such information in a timely manner in accordance with these rules.
As an internal structure, the Disclosure Policy Team, chaired by the President and CEO, has been established to determine,manage, review and supervise the content of Disclosure Policy Regulations, determine Material Disclosure Information, confirm the announcement of such information, and control risks.
The Disclosure Policy Regulations are applicable to all officers and employees, who are required to report necessary information to the Disclosure Policy Team as needed according to the scope of their duties based on the segregation of duties. Members of the Disclosure Policy Team are designated as information disclosure staff, and material disclosure information shall, in principle, be made through the information disclosure staff.
Information Disclosure and IR Activities
We believe that it is critical to gain your understanding of our business operations by presenting our business results, future prospective, and other corporate information fairly and accurately thorough IR activities. We have formulated a disclosure policy in order to disclose our corporate information in an appropriate and timely manner in accordance with laws, regulations, and the listing rules. All our officers and employees strive to disclose information based on the policy.
To enhance our management transparency, we intend not only to disclose information even more actively, but also to ensure smooth communication with shareholders and investors through IR activities.